G42 and Mubadala Merge Healthcare Entities to Form NewCo
Posted on 10/08/2022
On October 6, 2022, United Arab Emirates-based G42 and Mubadala Investment Company PJSC disclosed they will merge their respective healthcare businesses to create a new, first-of-its-kind integrated healthcare company. Operating at the forefront of medical research and innovation, the new company will become a vertically integrated healthcare company. Hasan Jasem Al Nowais has been appointed CEO of the new entity and will also continue to lead Mubadala Health. While continuing to build its network in the United Arab Emirates, the new company will consider opportunities for international expansion and new partnerships.
Across the two organizations, healthcare assets today include: Imperial College London Diabetes Centre; HealthPoint; National Reference Laboratory; HealthPlus; Danat Al Emarat; Moorfields Eye Hospital Abu Dhabi; Biogenix; the UAE’s Omics Center of Excellence; and Insights Research Organization & Solutions (IROS), the first UAE-based contract research organization specializing in healthcare research.
Sanad
Sanad is a global industrial services company with over 30-years’ experience in the aerospace sector and is wholly owned by Mubadala. In late September 2022, Sanad signed an exclusive framework agreement with TRIUMPH Product Support – Big Prairie, a provider of engine accessory maintenance, repair, and overhaul (MRO) services wholly owned by Triumph Group, Inc.
Keywords: Group 42 (G42).
